Announced Thu, 25 Jun · 12:24 IST
Mankind Pharma closes trading window from July 1 for Q1 results
Compliance View source PDF
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹2472.70
prior close
₹2485.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1-0.2+0.4+3.1+0.5+0.3+2.3+2.0+0.3+2.8——
Up moveDown movePending
AI summary
Mankind Pharma has closed its trading window for designated persons and their relatives from July 1, 2026. The window will reopen 48 hours after the company declares its unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The board meeting date to approve Q1 results will be announced later. This is a routine compliance under SEBI insider trading regulations.
Likely market impact
Routine insider trading compliance. Designated insiders cannot trade Mankind shares until 48 hours after Q1 results are declared. Watch for board meeting date.